Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study

PURPOSE: To compare the efficacy and safety of the combination of transcatheter arterial chemoembolization (TACE), Lenvatinib, and programmed cell death protein-1 (PD-1) inhibitors (combination group) with TACE (TACE group) in the treatment of patients with unresectable hepatocellular carcinoma (uHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Shuping, Zhang, Xiaobing, Wu, Yutian, Meng, Yan, Pan, Hongyu, Fang, Qiang, Hu, Lei, Zhang, Jin, Wang, Ruoyu, Wei, Lixin, Wu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068979/
https://www.ncbi.nlm.nih.gov/pubmed/35530353
http://dx.doi.org/10.3389/fonc.2022.874473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068979/
https://www.ncbi.nlm.nih.gov/pubmed/35530353
http://dx.doi.org/10.3389/fonc.2022.874473

Ejemplares similares